Invivyd and SPEAR Study Group initiate Phase 2 FLINTLOCK study
The study will evaluate monoclonal antibody VYD2311 for the potential treatment of Long COVID or post-vaccination syndrome.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.